All lobbying filings

W STRATEGIES, LLC

Lobbying for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · A trade group representing pharmaceutical research and biotechnology companies.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · $60,000.00 income · posted Jul 20, 2026

Official filing document

Bills named in this filing 1

HR 5376
Impacts and Outcomes for Health Career Training Act

Lobbying activity 1

Medicare/Medicaid

Public Law 119-21: One Big Beautiful Bill Act. Implementation of H.R.5376 Inflation Reduction Act. PBM reform legislation. 340(b) reform. FY 2027 National Defense Authorization Act. Issues around drug pricing including CMMI drug demonstration projects.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.